Sort
25,944 grants matching “neurodegeneration”
Advanced therapeutic for Parkinson's Disease
$1,554,020Milton H. Werner · Inhibikase Therapeutics · R44 · FY2017 · NS
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
$1,552,548Chien-Liang Glenn Lin · Ohio State University · U01 · FY2020 · AG
BOTANICAL CENTER FOR AGE-RELATED DISEASES
$1,551,580Purdue University West Lafayette · P50 · FY2000 · AT
Molecular Mechanisms of HIV-1 Associated Encephalopathy
$1,551,345David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2007 · NS
Mechanisms Regulating Chronic Immune Activation in the CNS
$1,551,284Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Aging of Emotion Circuitry and Risk for Alzheimer's disease: Impact of Sex, Immunity, and Fetal Origins
$1,551,207Jill M Goldstein · Massachusetts General Hospital · R01 · FY2024 · AG
ESTROGEN AND THE AGING BRAIN
$1,550,311Mount Sinai School Of Medicine Of Nyu · P01 · FY2000 · AG
Gene Therapy for Batten Disease
$1,549,439Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2009 · NS
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,547,324D. Martin Watterson · Northwestern University At Chicago · U01 · FY2023 · AG
A Caribbean Project for Clinical and Basic Neuroscience Research
$1,547,110Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2010 · NS
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,546,977D. Martin Watterson · Northwestern University At Chicago · U01 · FY2022 · AG
Advanced therapeutic for Parkinson's Disease
$1,546,730Milton H. Werner · Inhibikase Therapeutics · R44 · FY2020 · NS
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,546,636D. Martin Watterson · Northwestern University At Chicago · U01 · FY2024 · AG
NHGRI/DIR Cytogenetics and Microscopy Core
$1,546,027Amalia Dutra · National Human Genome Research Institute · ZIC · FY2019 · HG
In Vitro in Vivo Models of Alzheimer's Disease
$1,543,715University Of Pennsylvania · P01 · FY2005 · AG
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging
$1,541,445Ann Carolyn McKee · Boston University Medical Campus · U01 · FY2014 · NS
An Acquisition and Analysis Pipeline for Integrating MRI and Neuropathology in TBI-related Dementia and VCID
$1,541,272Andre Jan Willem Van Der Kouwe · Massachusetts General Hospital · U24 · FY2025 · NS
Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease
$1,541,121David Loewenstein · University Of Miami School Of Medicine · R01 · FY2025 · AG
Molecular Mechanisms of HIV-1 Associated Encephalopathy
$1,538,559David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2006 · NS
The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
$1,537,811Hemali Phatnani · Columbia University Health Sciences · R01 · FY2024 · NS
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$1,537,479John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Mitochondrial Dysfunction in Neurodegeneration of Aging
$1,537,309Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2013 · AG
DEVELOPMENT OF NOVEL NEURONAL AUTOPHAGY INDUCERS TO BLOCK NEURODEGENERATION AND TREAT ALS
$1,537,103J.David Gladstone Institutes · · FY2015 · Department of the Army
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,537,081Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
CNS & Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,534,900Janice Ellen Clements · Johns Hopkins University · P01 · FY2007 · MH